Literature DB >> 17128286

Elevated pressure selectively blunts flow-evoked vasodilatation in rat mesenteric small arteries.

F H Christensen1, T Hansen, E Stankevicius, N H Buus, U Simonsen.   

Abstract

BACKGROUND AND
PURPOSE: The present study investigated mechanisms underlying impaired endothelium-dependent vasodilatation elicited by elevating the intraluminal pressure in rat mesenteric small arteries. EXPERIMENTAL APPROACH: Arterial segments (internal diameter 316+/-2 microm, n=86) were mounted in a pressure myograph. The effect of elevating pressure from 50 to 120 mmHg for 1 h before resetting it to 50 mmHg was studied on endothelium-dependent vasodilatation. KEY
RESULTS: In arteries constricted with U46619 in the presence of indomethacin, shear stress generated by flow, evoked vasodilatation that was abolished by an inhibitor of nitric oxide (NO) synthase, asymmetric dimethylarginine (1 mM), whereas acetylcholine-induced vasodilatation was unchanged. After elevation of intraluminal pressure for 1 h and then resetting it to 50 mmHg, vasodilatation induced by shear stress and the NO donor, S-nitrosopenicillamine was inhibited, while vasodilatation induced by a guanylyl cyclase activator, BAY 412272, and acetylcholine was unaltered. Superoxide levels sensitive to polyethylene glycol superoxide dismutase were increased in segments exposed to elevated pressure. A superoxide scavenger, tempol (300 microM), a general endothelin receptor antagonist, SB 217242 and the selective ET(A) receptor antagonist, BQ 123 preserved shear stress-evoked vasodilatation. CONCLUSIONS AND IMPLICATIONS: The present study shows that transient exposure to an elevated intraluminal pressure selectively inhibits flow-evoked NO-mediated vasodilatation, probably through activation of endothelin receptors and increased formation of superoxide. In contrast, elevation of pressure did not affect the acetylcholine-evoked endothelium-derived hyperpolarizing factor type vasodilatation in mesenteric small arteries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17128286      PMCID: PMC2013851          DOI: 10.1038/sj.bjp.0706965

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

1.  Depletion of intracellular Ca2+ stores enhances flow-induced vascular dilatation in rat small mesenteric artery.

Authors:  Cuiling Liu; Ching-Yuen Ngai; Yu Huang; Wing-Hung Ko; Min Wu; Guo-Wei He; Christopher J Garland; Kim A Dora; Xiaoqiang Yao
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

2.  Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase.

Authors:  S Klöss; A Bouloumié; A Mülsch
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

Review 3.  Endothelium-dependent contractions in hypertension.

Authors:  Paul M Vanhoutte; Michel Feletou; Stefano Taddei
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

4.  ETA receptor blockade attenuates hypertension and decreases reactive oxygen species in ETB receptor-deficient rats.

Authors:  Ahmed A Elmarakby; E Dabbs Loomis; Jennifer S Pollock; David M Pollock
Journal:  J Cardiovasc Pharmacol       Date:  2004-11       Impact factor: 3.105

5.  Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension.

Authors:  A D Dobrian; S D Schriver; R L Prewitt
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

6.  Elevated perfusion pressure upregulates endothelin-1 and endothelin B receptor expression in the rabbit carotid artery.

Authors:  M Lauth; M M Berger; M Cattaruzza; M Hecker
Journal:  Hypertension       Date:  2000-02       Impact factor: 10.190

7.  Relaxation in different-sized rat blood vessels mediated by endothelium-derived hyperpolarizing factor: importance of processes mediating precontractions.

Authors:  H Tomioka; Y Hattori; M Fukao; A Sato; M Liu; I Sakuma; A Kitabatake; M Kanno
Journal:  J Vasc Res       Date:  1999 Jul-Aug       Impact factor: 1.934

8.  Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries.

Authors:  N H Buus; U Simonsen; H K Pilegaard; M J Mulvany
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

9.  Rapid endothelial cell-selective loading of connexin 40 antibody blocks endothelium-derived hyperpolarizing factor dilation in rat small mesenteric arteries.

Authors:  Simon Mather; Kim A Dora; Shaun L Sandow; Polly Winter; Christopher J Garland
Journal:  Circ Res       Date:  2005-07-21       Impact factor: 17.367

10.  Antagonism of ANG II type 1 receptors protects the endothelium during the early stages of renal hypertension in rats.

Authors:  J Hoshino; T Nakamura; T Kurashina; Y Saito; H Sumino; Z Ono; H Sakamoto; K Kowase; R Nagai
Journal:  Am J Physiol       Date:  1998-12
View more
  4 in total

1.  Age-dependent impact of CaV 3.2 T-type calcium channel deletion on myogenic tone and flow-mediated vasodilatation in small arteries.

Authors:  Miriam F Mikkelsen; Karl Björling; Lars Jørn Jensen
Journal:  J Physiol       Date:  2016-02-18       Impact factor: 5.182

2.  Different mechanisms involved in liraglutide and glucagon-like peptide-1 vasodilatation in rat mesenteric small arteries.

Authors:  Maj Bangshaab; Alejandro Gutierrez; Khiem Dinh Huynh; Jakob Schöllhammer Knudsen; Daniel Dias Rufino Arcanjo; Asbjørn G Petersen; Jørgen Rungby; Michael Gejl; Ulf Simonsen
Journal:  Br J Pharmacol       Date:  2018-12-09       Impact factor: 8.739

Review 3.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

4.  Nanostructured Lipid Carriers Deliver Resveratrol, Restoring Attenuated Dilation in Small Coronary Arteries, via the AMPK Pathway.

Authors:  Cai Astley; Chahinez Houacine; Azziza Zaabalawi; Fiona Wilkinson; Adam P Lightfoot; Yvonne Alexander; Debra Whitehead; Kamalinder K Singh; May Azzawi
Journal:  Biomedicines       Date:  2021-12-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.